Oncolytic Virus Immunotherapy Market Scope And Analysis

  • Report Code : TIPRE00016666
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Oncolytic Virus Immunotherapy Market Analysis, Size, and Growth (2025-2031)

Buy Now

Oncolytic Virus Immunotherapy Market Report Oncolytic Virus Immunotherapy Market Size and Share Oncolytic Virus Immunotherapy Market Scope and Analysis

Oncolytic Virus Immunotherapy Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Virus Type
  • Herpes Simplex Virus
  • Vaccinia Virus
  • Adenovirus
  • Reovirus
By Route of Administration
  • Intratumoral
  • Intravenous
By Application
  • Melanoma
  • Non-small Cell Lung Cancer
  • Pancreatic Cancer
  • Breast Cancer
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Amgen Inc
  • Merck KGaA
  • Shanghai Sunway Biotech Co Ltd
  • TILT Biotherapeutics
  • Oncorus Inc
  • Oncolys BioPharma Inc
  • Sorrento Therapeutics Inc
  • Oncolytics Biotech Inc
  • SillaJen Inc